Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope |
Hong, Kwon-Pyo
(Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University)
Kang, Sung-Hee (Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University) Lee, Kyoung-Mee (Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University) Ji, Gil-Yong (Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University) Yoon, Sang-Soon (Research Institute, DiNonA Inc.) Kim, Jong-Suk (Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University) Son, Bo-Ra (Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University) Lee, Dong-Geun (Department of Plastic and Reconstructive Surgery, College of Medicine and Medical Research Institute, Chungbuk National University) Lee, Ok-Jun (Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University) Song, Hyung-Geun (Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University) |
1 | Lanza F, Healy L, Sutherland DR: Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15;1-13, 2001 |
2 | Nishio H, Tada J, Hashiyama M, Hirn J, Ingles-Esteve J, Suda T: MC7. CD34 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEG, Goyert SM, Mason DY, Miyasaka M, et al., editors. Leucocyte typing VI. White cell differentiation antigens. Proceedings of the 6th International Workshop and Conference; 1996 Nov 10-14; Kobe, Japan. New York, London: Garland Publishing Inc.; p974- 984, 1997 |
3 | Titley I, Healy LE, Scott M, Amos TA, Gordon MY: Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues. Bone Marrow Transplant 16;611-616, 1995 |
4 | Titley I, Healy LE, Scott M, Amos TA, Gordon MY: Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues. Bone Marrow Transplant 16;611-616, 1995 |
5 | Cannovo N, Bossy D, Hirn J: Significant diversity of the reactivity of monoclonal CD34 antibodies requires an extended classification of the CD34 epitopes. Lab Hematol 3;253-260, 1997 |
6 | Serke S, Huhn D: Expression of class I, II and III epitopes of the CD34 antigen by normal and leukemic hemopoietic cells. Cytometry 26;154-160, 1996 DOI ScienceOn |
7 | Steen R, Tjonnfjord GE, Gaudernack G, Brinch L, Egeland T: Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells. Br J Haematol 94;597-605, 1996 DOI ScienceOn |
8 | Lanza F, Moretti S, Castagnari B, Latorraca A, Rigolin GM, Bardi A, Castoldi G: CD34+ leukemic cells assessed by different CD34 monoclonal antibodies. Leuk Lymphoma 18(Suppl 1);25-30, 1995 DOI |
9 | Weinberg DS, Benjamin RJ: QBEnd10 (CD34) antibody is unsuitable for routine use in the ISHAGE CD34+ cell determination assay. J Hematother 5;599-603, 1996 DOI ScienceOn |
10 | Sovalat H, Racadot E, Henon P, Fuchs P, Lewandowski H, Billot M: Comparative analysis of class I, II and III epitope- detecting CD34 monoclonal antibodies by quantitative flow cytometry. Hematol Cell Ther 40;259-268, 1998 |
11 | Sutherland DR, Anderson L, Nayar R, Keeney M, Chin Yee I. The ISHAGE Guidelines for CD34+ cell determination: Applications in autologous and allogenic blood and marrow transplantation. In: Bone Marrow Transplantation: A Practical Approach. Ball E, Lister J, editors. Churchill Livingstone; p239-246, 2000 |
12 | Civin CI, Small D: Purification and expansion of human hematopoietic stem/progenitor cells. Ann N Y Acad Sci 770;91-98, 1995 DOI |
13 | Greaves MF, Brown J, Molgaard HV, Spurr NK, Robertson D, Delia D, Sutherland DR: Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia 6(Suppl 1);31-36, 1992 |
14 | Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5;213-226, 1996 DOI ScienceOn |
15 | Siena S, Bregni M, Brando B, Belli N, Lansdorp PM, Bonadonna G, Gianni M: Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. Haematologica 76;330-333, 1991 |
16 | Katz FE, Tindle R, Sutherland DR, Greaves MF: Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk Res 9;191-198, 1985 DOI ScienceOn |
17 | Shpall EJ, Jones RB, Franklin W: Transplantation of autologous CD34+ hematopoietic progenitor cells into breast cancer patients following high-dose chemotherapy. J Clin Oncol 12;28-32, 1994 DOI |
18 | Greaves MF, Titley I, Colman SM, Buhring H-J, Campos L, Castoldi GL, et al: Report on the CD34 cluster Workshop. In: Schlossman S, et al editors. Leukocyte Typing V. Oxford University Press; p840-846, 1995 |
19 | Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J: Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 93;1858- 1868, 1999 |
20 | Civin CI, Trischmann TM, Fackler MJ, Bernstein ID, Buhring HJ, Campos L, et al: M7.1. Report on the CD34 cluster workshop. In: Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, et al., editors. Leukocyte typing IV. White cell differentiation antigens. Proceedings of the 4th International Workshop and Conference; 1989 Feb 21-25; Vienna, Austria. Oxford, New York, Tokyo: Oxford University Press; p818-825, 1989 |
21 | Beschorner WE, Civin CI, Strauss LC: Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol 119;1-4, 1985 |
22 | Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133;157-165, 1984 |
23 | Tindle RW, Nichols RA, Chan L, Campana D, Catovsky D, Birnie GD: A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res 9;1-9, 1985 DOI ScienceOn |
24 | Watt SM, Karhi K, Gatter K, Furley AJ, Katz FE, Healy LE, Altass LJ, Bradley NJ, Sutherland DR, Levinsky R, et al: Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1;417-426, 1987 |
25 | Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF: Expression of the CD34 gene in vascular endothelial cells. Blood 75;2417-2426, 1990 |
26 | Sutherland DR, Keating A: The CD34 antigen: structure, biology, and potential clinical applications. J Hematother 1;115-129, 1992 DOI ScienceOn |
27 | Macey MG, McCarthy DA, van Agthoven A, Newland AC: How should CD34+ cells be analysed? A study of three classes of antibody and five leucocyte preparation procedures. J Immunol Methods 204;175-188, 1997 DOI ScienceOn |